GlobalData on MSN2d
Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-lifeThe company’s weight loss therapy was able to sustain itself for up to 40 days in obese patients after a single injection.
Research reveals how exercise triggers the release of specialized myokines that regulate metabolism, build muscle, reduce ...
Vietnam Investment Review on MSN2d
Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U S FDA Clearance of IND Application for ASC47 in Combination with SemaglutideASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...
1don MSN
“By identifying individuals in a preclinical obesity phase, where they are not yet classified as obese but are showing signs ...
Having a good memory is generally considered a useful trait, whether we're talking about muscle memory or cognitive function.
Everyone knows that fat is where the extra calories you eat end up and the main reason your clothes fit too tightly. Body fat ...
Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...
Having a good memory is generally considered a useful trait, whether we're talking about muscle memory or cognitive function.
Researchers have found that women who exhibit disturbed eating behaviors and engage in low physical activity tend to have more central body fat and a higher risk of metabolic low-grade inflammation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback